Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
BI 44370 TA in Acute Migraine Attack
- Status
- COMPLETED
- Phase
- PHASE2
BI 10773 add-on to Metformin in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.
- Status
- TERMINATED
- Phase
- PHASE2
Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks
- Status
- COMPLETED
- Phase
- PHASE1
A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
- Status
- COMPLETED
- Phase
- PHASE3
Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis
- Status
- WITHDRAWN
- Phase
- PHASE2
Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120
- Status
- COMPLETED
- Phase
- PHASE1
LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
- Status
- COMPLETED
- Phase
- PHASE2
A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2